Wilmington Savings Fund Society’s Pacific Biosciences PACB Stock Holding History

Wilmington Savings Fund Society’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.2K	Hold	2,500	–	–	﹤0.01%	1282
2026 Q1	$3.3K	Hold	2,500	–	–	﹤0.01%	1302
2025 Q4	$4.67K	Hold	2,500	–	–	﹤0.01%	1254
2025 Q3	$3.2K	Hold	2,500	–	–	﹤0.01%	1271
2025 Q2	$3.1K	Hold	2,500	–	–	﹤0.01%	1829
2025 Q1	$2.95K	Hold	2,500	–	–	﹤0.01%	1854
2024 Q4	$4.58K	Hold	2,500	–	–	﹤0.01%	1819
2024 Q3	$4.25K	Buy	+2,500	New	+$4.11K	﹤0.01%	1817

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wilmington Savings Fund Society's PACB Position: Q2 2026 in Review

Wilmington Savings Fund Society held its Pacific Biosciences (PACB) position steady in Q2 2026 at 2,500 shares worth $4.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1282.

Wilmington Savings Fund Society first reported a position in PACB in Q3 2024 and has held it in 8 quarters since. The position peaked at $4.67K in Q4 2025. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

Wilmington Savings Fund Society held 2,500 shares of Pacific Biosciences worth $4.2K as of Q2 2026.
Wilmington Savings Fund Society left its Pacific Biosciences share count unchanged in Q2 2026.
Pacific Biosciences made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #1282 holding.
Wilmington Savings Fund Society first reported a position in Pacific Biosciences in Q3 2024 and has held it in 8 quarters since.
Wilmington Savings Fund Society's Pacific Biosciences position peaked at $4.67K in Q4 2025.
223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.